2 ASX 200 shares I'd want to receive as a present today

Merry Christmas! Are there any stocks under your tree?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I hope everyone who celebrates today is having a wonderful, festive start to their day. Did you receive a pair of socks today? What about a pair of stocks? Receiving S&P/ASX 200 Index (ASX: XJO) shares as a gift is probably not the most popular present, but I'd love it.

Wouldn't it be great to receive a present that gives you cash year after year, and the gift (hopefully) becomes more and more valuable as time goes on?

If I could choose what ASX 200 shares I receive as a present, that'd mean I don't have to pay for them myself or worry about their valuation. It could be fun to receive some of the most exciting ASX 200 shares as a present, which have exceptionally high price-earnings (P/E) ratios.

I'd happily receive some shares of the below two businesses.

A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus may well be the best ASX 200 share out there. Not only does it have enormous profit margins, but its revenue and profit growth outlook is very impressive.

This company describes itself as a leading healthcare informatics business, providing a full range of medical imaging software and services to hospitals, imaging centres, and healthcare groups worldwide. It claims to offer one of the most comprehensive end-to-end offerings in healthcare imaging.

Pro Medicus' operating profit (EBIT) margin is over 60%, one of the highest on the ASX. Any new revenue can also significantly increase the net profit after tax (NPAT).

It's regularly winning new contracts – earlier this week, it announced a A$30 million, 7-year deal with Duly Health and Care, the largest independent, multi-specialty physician-directed medical group in the Midwest USA.

If it continues winning contracts, then the outlook will keep improving.

Why do I want it as a present rather than buying it myself? According to the forecast on Commsec, the ASX 200 share is valued at close to 235x FY25's estimated earnings.

That's an astonishingly high price-earnings (P/E) ratio. But, if there were one business on the ASX to say it's justified, I'd say it's this one.

TechnologyOne Ltd (ASX: TNE)

In my books, TechnologyOne is another of the most impressive companies on the ASX. It claims to be Australia's largest enterprise software company, with locations across six countries. Its main offering is a global software as a service (SaaS) enterprise resource planning (ERP) solution that transforms business. Its customer base includes more than 1,300 leading corporations, government agencies, local councils, and universities.

When I consider the appeal of an ASX growth share, I ask myself an important question: How big can the business' operations/profit become in five or ten years?

The more a business can grow, the more likely it is to deliver pleasing shareholder returns.

The company's long-term target is to reach at least $1 billion of annual recurring revenue (ARR) by FY30, thanks to a combination of a high loyalty rate and strong growth. When the company reported its FY24 result, it said its total ARR was $470.2 million.

It's aiming to achieve revenue growth of at least 15% from its existing customer base each year as customers take up more of the ASX 200 share's products and modules. The average ARR from customers has grown from $100,000 in FY12 to almost $400,000 in FY24.

The company is aiming to reach a profit before tax (PBT) margin of 35% in the coming years, up from 30% in FY24.

Overall, I think this business has a lot of growth potential, and I'd love to be gifted some of its shares and financially contribute to its success.

According to the forecasts on Commsec, the TechnologyOne share price is valued at 75x FY25's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

An army soldier in combat uniform takes a phone call in the field.
Opinions

Forget DroneShield shares, I'd buy these ASX defence stocks instead

These ASX defence stocks look like they have a better upside than DroneShield shares over the next 12 months.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Cheap Shares

3 super cheap ASX 200 shares I'd buy right now

These ASX 200 shares are trading at dirt-cheap prices right now.

Read more »

Happy woman looking for groceries. as she watches the Coles share price and Woolworths share price on her phone
Opinions

3 reasons why the Coles share price is a buy

It seems like a great time to invest in this supermarket giant.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Opinions

A rare buying opportunity in 1 of Australia's top shares?

This business looks very undervalued to me!

Read more »

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Technology Shares

I was going to buy these ASX tech stocks. Now, I'm not so sure

When the facts change, so should our buying...

Read more »

A boy standing on the edge of a cliff peers at a red flag in the distance through binoculars.
Opinions

Are Pro Medicus shares a buy right now?

Pro Medicus shares are down 36% this year. What now?

Read more »

Young girl peeps over the top of her red piggy bank, ready to put coins in it.
Opinions

NAB shares: Are they cheap enough to buy after the latest drop?

NAB shares are down nearly 10%. Is this a buying window?

Read more »